ROBIN SWENSEN: Open Payments
NPI 1912181678 · BRENTWOOD, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,379 in 57 payments from 23 companies in 2025. Trend: 2023 $4,048 · 2024 $2,722 · 2025 $5,379
Food & beverage: $5,379
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 5 | $606 |
| Janssen Pharmaceuticals, Inc | 4 | $499 |
| Teva Pharmaceuticals USA, Inc. | 4 | $386 |
| Alkermes, Inc. | 3 | $366 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $364 |
| ABBVIE INC. | 7 | $324 |
| Vanda Pharmaceuticals Inc. | 7 | $320 |
| E.R. Squibb & Sons, L.L.C. | 3 | $265 |
| AstraZeneca Pharmaceuticals LP | 2 | $235 |
| Janssen Biotech, Inc. | 2 | $231 |
Products named: Auvelity, CAPLYTA, INVEGA SUSTENNA, COBENFY, AUSTEDO XR, LYBALVI, FANAPT, TREMFYA.
Industry payments across TN — which companies pay providers there.
